Safety study of VB19055 in healthy volunteers
Part of Heart & circulation clinical trials.
This trial tests a new drug (VB19055) in healthy volunteers to see how safe it is and how the body processes it. Participants will be watched closely and may help find the right dose for future studies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy volunteer between 18 and 50 years old.
- Your body mass index (BMI) must be between 18 and 26, and you must weigh at least 110 lbs (men) or 99 lbs (women).
- You cannot be a smoker or heavy drinker (more than 14 alcoholic drinks per week).
- You cannot have taken any medications (including over-the-counter drugs, vitamins, or supplements) in the 14 days before the study.
- Women must agree to use highly effective birth control and have a negative pregnancy test; men must use effective contraception for 3 months after the last dose.
- You must not have donated blood or lost more than 400 ml of blood in the past 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new investigational medicine called VB19055 for people whose high blood pressure is not controlled even though they are already taking multiple blood pressure medications. The trial aims to see if this new drug can help lower blood pressure more effectively.
This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.
This trial tests a new medicine, F230, in healthy people for the first time. The goal is to check how safe it is and how the body handles it. You might consider this if you are a healthy adult looking to help advance medical research.
This trial tests a new medicine in healthy people to see how it is absorbed and broken down by the body, and to make sure it is safe. If you join, you will take the medicine under fasting conditions and have regular blood tests.
This trial tests a new tablet called VV261 in healthy volunteers to see how safe it is and how the body processes it. It is an early study to gather important information before larger trials.
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
Hear when a new High blood pressure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.